TyraTech Inc. (AIM: TYR/TYRU), a life sciences company focusing on nature-derived insect and parasite control products, announces that at the Annual General Meeting of the Company held on 29 July 2015, all resolutions were duly passed.
For further information please contact:
TyraTech Inc. Alan Reade, Non-Executive Chairman Bruno Jactel, Chief Executive Officer |
Tel: +1 919 415 4340 Tel: +1 919 415 4287 |
SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44 203 368 3551 Tel: +44 203 368 3552 |
Allenby Capital Limited , Joint Broker Chris Crawford |
Tel: +44 20 3328 5656 |
Whitman Howard Limited, Joint Broker Ranald McGregor-Smith/ Niall Devins |
Tel: +44 20 7659 1240 |
Walbrook, Financial PR and IR Nick Rome/ Guy McDougall |
Tel: +44 20 7933 8790 |
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.